Tempus AI, Inc. Class A Common Stock (TEM)vsVSee Health, Inc. (VSEE)
TEM
Tempus AI, Inc. Class A Common Stock
$46.76
-4.24%
HEALTHCARE · Cap: $8.73B
VSEE
VSee Health, Inc.
$0.24
-8.85%
HEALTHCARE · Cap: $11.24M
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 8716% more annual revenue ($1.27B vs $14.43M). TEM leads profitability with a -19.3% profit margin vs -69.8%. TEM earns a higher WallStSmart Score of 31/100 (F).
TEM
Avoid31
out of 100
Grade: F
VSEE
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for TEM.
Margin of Safety
+89.7%
Fair Value
$3.13
Current Price
$0.24
$2.89 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 83.0% year-over-year
Attractively priced relative to earnings
Conservative balance sheet, low leverage
18.7% revenue growth
Areas to Watch
Trading at 16.9x book value
0.0% earnings growth
ROE of -89.5% — below average capital efficiency
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -2.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 83.0% demonstrates continued momentum.
Bull Case : VSEE
The strongest argument for VSEE centers on P/E Ratio, Debt/Equity, Revenue Growth. Revenue growth of 18.7% demonstrates continued momentum.
Bear Case : TEM
The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.
Bear Case : VSEE
The primary concerns for VSEE are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
TEM profiles as a hypergrowth stock while VSEE is a growth play — different risk/reward profiles.
TEM is growing revenue faster at 83.0% — sustainability is the question.
VSEE generates stronger free cash flow (-6M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TEM scores higher overall (31/100 vs 29/100) and 83.0% revenue growth. VSEE offers better value entry with a 89.7% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →VSee Health, Inc.
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
VSee Health, Inc. is a pioneering force in the telehealth industry, delivering secure and user-centric video communication solutions specifically designed for healthcare providers and patients. The comprehensive platform offers a suite of functionalities, including remote patient monitoring, asynchronous messaging, and electronic medical record (EMR) interoperability, aimed at optimizing healthcare delivery efficiency and quality across various specialties. With an unwavering focus on enhancing patient engagement and accessibility, VSee serves a diverse global clientele of healthcare institutions. As virtual care continues to gain traction, VSee Health is strategically positioned to leverage its technological innovations and expand its influence within the evolving healthcare market.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?